Evidence map›Paper›PMID 41754912›Full record

ArticlePharmaceutics2026

Polynuclear Silver(I)-Quinoxaline Complex: Comprehensive Structural Characterization, Antimycobacterial Properties and DNA/BSA Binding Study.

Ghada Bouz, Nevena L Stevanović, Marta Počkaj, Tina P Andrejević, Iztok Turel, Ondřej Jand'ourek, Klára Konečná, Žiko Milanović, Kristina Milisavljević, Biljana Đ Glišić

Abstract read
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ghada BouzFaculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 03 Hradec Králové, Czech Republic.ORCID 0000-0003-2024-5788
Nevena L StevanovićDepartment of Chemistry, Faculty of Science, University of Kragujevac, R. Domanovića 12, 34000 Kragujevac, Serbia.ORCID 0000-0003-3261-478X
Marta PočkajFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia.ORCID 0000-0002-6306-1631
Tina P AndrejevićDepartment of Chemistry, Faculty of Science, University of Kragujevac, R. Domanovića 12, 34000 Kragujevac, Serbia.ORCID 0000-0002-9537-5926
Iztok TurelFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia.ORCID 0000-0001-6776-4062
Ondřej Jand'ourekFaculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 03 Hradec Králové, Czech Republic.ORCID 0000-0003-4633-2062
Klára KonečnáFaculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 03 Hradec Králové, Czech Republic.ORCID 0000-0001-5670-7767
Žiko MilanovićDepartment of Science, Institute for Information Technologies Kragujevac, University of Kragujevac, Liceja Knezevine Srbije 1A, 34000 Kragujevac, Serbia.
Kristina MilisavljevićDepartment of Science, Institute for Information Technologies Kragujevac, University of Kragujevac, Liceja Knezevine Srbije 1A, 34000 Kragujevac, Serbia.
Biljana Đ GlišićDepartment of Chemistry, Faculty of Science, University of Kragujevac, R. Domanovića 12, 34000 Kragujevac, Serbia.ORCID 0000-0002-6343-8611

Funding

European Cooperation in Science and Technology CA21145Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-136/2025-03/200122Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-136/2025-03/200378Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-137/2025-03/200122The Slovenian Research and Innovation Agency Infrastructure Programme No. I0-0022The Slovenian Research and Innovation Agency P1-0175
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimycobacterial activityDNA interactionN-substituted quinoxaline-2-carboxamidesprotein interactionsilver(I) complexes

Identifiers

PMID41754912
PMCPMC12944352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.